GT&F® and Diabetes

Diabetes Mellitus is caused by high blood glucose. High blood glucose condition will lead to a fragile blood vessel, thus developing complication of blood circulatory and nervous system. Type 2 diabetes has been thought to be caused by insufficient insulin secretion or ineffective utilization of insulin in human body. However, recent medical research discovered that the lacking of GTF is the main cause of type 2 diabetes.
Insulin resistance is characterized mainly by the weak responsiveness of tissues to insulin. It is a known risk factor leading to the development of type 2 diabetes and cardiovascular disorders. (Chen et al., 2009)

When blood glucose level increases, insulin level will also increase. In the presence of suitable amount of chromium in usable form, chromium will potentiating the action of insulin. Therefore, less insulin is required and circulating insulin declines with a corresponding stabilization of glucose concentration level. (Anderson et al., 1991)

Chromium in the serum of type 2 diabetic (0.2μg/L) is lower as compared to normal people (0.5μg/L).
(Davies et al., 1997)

CLINICAL TRIAL
A randomized, double-blind, placebo-controlled clinical trial was conducted in 2004 by a research scientist team lead by the former head of Taiwan National College of Medicine, Professor Dr. Tai Dong Yan. This world standard clinical trials took place at four renowned hospitals, which are…
National Taiwan University Hospital Tri-Service General Hospital
National Cheng Kung University Hospital Tai Chung Veteran’s General Hospital
  The clinical trial results showed that:

……by supplementing daily intake with 400mcg of chromium within 6 weeks, type 2 diabetics experienced lower fasting blood glucose level as well as LDL cholesterol. Meanwhile, HDL cholesterol improved…
SCIENTIFIC RESEARCH
Research also indicates that GTF is found to be effective in controlling diabetes; as published in A Journal of Pharmacology and Therapeutics; Diabetes, Obesity And Metabolism, 2009…

…chromium group can significantly enhance insulin and protentiating the action of insulin thus leading to uptake of glucose into cell by opening the gate of membrane cell. With this, glucose is converted into energy for conducting body functions.

Therefore, GT&F® product is effective as an adjunctive therapy for management of type 2 diabetes mellitus along with diets, exercise and traditional pharmacotherapy.